In an additional cohort of 124 AML/M2 patients (Appendix Table S5), THAP10 mRNA levels were 0.9‐fold lower in AML1‐ETO+ than AML1‐ETO− cases (Fig 2D). The gene discussed is RUNX1; the disease is acute myeloid leukemia.